Concepedia

Fadi S. Braiteh

FS

Statistics

Publications

35

Citations

4.4K

H-Index

22

Active since

2005

Affiliations

Comprehensive Cancer Centers of Nevada(Current)

Sarah Cannon

Tennessee Oncology

The US Oncology Network

McKesson (United States)

Fadi S. Braiteh is an author at Comprehensive Cancer Centers of Nevada specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2005–2021

35

Publications

35

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

Thomas Powles, Joseph P. Eder, Gregg Fine et al. · Nature · 2014 · 2.4K citations

, , +12

Liposome‐encapsulated curcumin

Li Lan, Fadi S. Braiteh, Razelle Kurzrock · Cancer · 2005 · 643 citations · Full text

, , +17

Abstract 2859: Inhibition of PD-L1 by MPDL3280A leads to clinical activity in patients with metastatic triple-negative breast cancer (TNBC)

Leisha A. Emens, Fadi S. Braiteh, Philippe A. Cassier et al. · Cancer Research · 2015 · 210 citations

, , +17

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial

Harry H. Yoon, Johanna C. Bendell, Fadi S. Braiteh et al. · Annals of Oncology · 2016 · 144 citations · Full text

, , +13

Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses

Peter Schmid, Cristina Cruz, Fadi S. Braiteh et al. · Cancer Research · 2017 · 112 citations

, , +17

1–5 of 35